CAGE conferred resistance to epidermal growth factor receptor (EGFR)-TKIs (EGFR tyrosine kinase inhibitors) by promoting autophagy via binding to Beclin1 in non-small cell lung cancer cells [113]. Here, EGFR is linked to non-small cell lung carcinoma.